Partial response to erlotinib in a patient with imatinib-refractory sacral chordoma

Overview of attention for article published in Clinical Sarcoma Research, December 2020

Altmetric Badge

About this Attention Score

So far, Altmetric has seen 7 X posts from 7 X users, with an upper bound of 6,818 followers.

Great sir

RT @samdoc_mamc: Our paper showing excellent response to #Erlotinib in #EGFR expressing met #Chordoma . More than 18m and still going on. #…

RT @samdoc_mamc: Our paper showing excellent response to #Erlotinib in #EGFR expressing met #Chordoma . More than 18m and still going on. #…

RT @samdoc_mamc: Our paper showing excellent response to #Erlotinib in #EGFR expressing met #Chordoma . More than 18m and still going on. #…

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 3 additional X posts.